Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Theravance Biopharma, Inc. (TBPH) completed its merger with Zymeworks Inc. on September 23, 2026, and survived as a wholly owned subsidiary of Zymeworks. The ownership amendment reports that the reporting persons no longer beneficially owned the issuer’s ordinary shares after the merger.
Each ordinary share outstanding immediately before the merger, including shares held by Madison Avenue International LP, was cancelled and converted into the right to receive $17.00 in cash, without interest, and one contingent value right. Madison Avenue International LP, Madison Avenue Partners, LP, EMAI Management, LLC, Madison Avenue GP, LLC, Caraway Jackson Investments LLC and Eli Samaha reported zero beneficially owned shares; the reporting persons ceased to be beneficial owners of more than 5% of the class.
Key Figures
Cash consideration per ordinary share:$17.00 in cashContingent value rights per ordinary share:1 contingent value rightBeneficially owned ordinary shares:0 shares+2 more
5 metrics
Cash consideration per ordinary share$17.00 in cashRight to receive this amount, without interest, for each ordinary share outstanding immediately before the merger
Contingent value rights per ordinary share1 contingent value rightRight to receive one for each ordinary share outstanding immediately before the merger
Beneficially owned ordinary shares0 sharesMadison Avenue International LP and the other reporting persons reported zero as of September 23, 2026
Reported ownership percentageapproximately 0%Reporting persons’ beneficial ownership as of September 23, 2026
Ordinary shares outstanding51,918,754 sharesAs of July 31, 2026; basis stated for the ownership percentage
Key Terms
contingent value right, beneficially owned
2 terms
contingent value rightfinancial
"one contingent value right"
A contingent value right is a special security that gives its holder the right to receive one or more future payments only if specified events happen, such as a product reaching a sales target or getting regulatory approval. It matters to investors because it offers potential extra payout tied to uncertain outcomes—like a bet that a project will succeed—so it can add upside to a deal while also carrying extra risk and valuation uncertainty.
beneficially ownedfinancial
"no longer beneficially owned any Ordinary Shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did each TBPH ordinary share receive in the merger?
Each ordinary share outstanding immediately before the merger was converted into the right to receive $17.00 in cash, without interest, and one contingent value right.
How many TBPH ordinary shares did the reporting persons own after the merger?
The reporting persons reported zero beneficially owned ordinary shares as of September 23, 2026, and ceased to be beneficial owners of more than 5% of the class.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 6)
Theravance Biopharma, Inc.
(Name of Issuer)
Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares")
(Title of Class of Securities)
(CUSIP Number)
09/23/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
Madison Avenue International LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
Madison Avenue Partners, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
EMAI Management, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
Madison Avenue GP, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
Caraway Jackson Investments LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
Eli Samaha
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Theravance Biopharma, Inc.
(b)
Address of issuer's principal executive offices:
Ugland House, South Church Street, George Town, Grand Cayman KY1-1104
Item 2.
(a)
Name of person filing:
The names of the persons filing this statement on Schedule 13G (collectively, the "Reporting Persons") are:
* Madison Avenue International LP,
* Madison Avenue Partners, LP,
* EMAI Management, LLC,
* Madison Avenue GP, LLC,
* Caraway Jackson Investments LLC, and
* Eli Samaha.
(b)
Address or principal business office or, if none, residence:
The principal business address for each of the Reporting Persons is 150 East 58th St, 14th Fl, New York, NY 10155.
(c)
Citizenship:
Madison Avenue International LP is a Cayman Islands exempted limited partnership. Madison Avenue Partners, LP is a Delaware limited partnership. Each of EMAI Management, LLC, Madison Avenue GP, LLC and Caraway Jackson Investments LLC is a Delaware limited liability company. Mr. Samaha is a citizen of the United States of America.
(d)
Title of class of securities:
Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares")
(e)
CUSIP No.:
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
On September 23, 2026, the Issuer completed its previously announced merger (the "Merger") with Zymeworks Inc., a Delaware corporation ("Zymeworks"), pursuant to the Agreement and Plan of Merger, dated as of June 28, 2026, by and among the Issuer, Zymeworks and Zymeworks Merger Sub 1, a wholly owned subsidiary of Zymeworks ("Merger Sub"). Pursuant to the Merger, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Zymeworks, and each Ordinary Share issued and outstanding immediately prior to the effective time of the Merger, including each Ordinary Share held by Madison Avenue International LP, was cancelled and converted into the right to receive (i) $17.00 in cash, without interest, and (ii) one contingent value right.
As a result of the Merger, as of September 23, 2026, Madison Avenue International LP no longer beneficially owned any Ordinary Shares, and the Reporting Persons ceased to be the beneficial owners of more than five percent of the Ordinary Shares.
Prior to the Merger, Madison Avenue Partners, LP and Madison Avenue GP, LLC, as the investment manager and general partner of Madison Avenue International LP, respectively, may have been deemed to be the beneficial owner of the Ordinary Shares owned directly by Madison Avenue International LP.
Prior to the Merger, EMAI Management, LLC, as the general partner of Madison Avenue Partners, LP, may have been deemed to be the beneficial owner of the Ordinary Shares owned directly by Madison Avenue International LP.
Prior to the Merger, Caraway Jackson Investments LLC, as the owner of Madison Avenue GP, LLC, may have been deemed to be the beneficial owner of the Ordinary Shares owned directly by Madison Avenue International LP.
Prior to the Merger, Mr. Samaha, as the non-member manager of Madison Avenue GP, LLC, the managing member of EMAI Management, LLC, and the majority owner of Caraway Jackson Investments LLC, may have been deemed to be the beneficial owner of the Ordinary Shares owned by Madison Avenue International LP.
(b)
Percent of class:
The following percentage is based on 51,918,754 Ordinary Shares outstanding as of July 31, 2026, as disclosed in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 11, 2026.
As of September 23, 2026, the Reporting Persons may be deemed to have beneficially owned approximately 0% of the outstanding Ordinary Shares.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Cover Pages Items 5-9.
(ii) Shared power to vote or to direct the vote:
See Cover Pages Items 5-9.
(iii) Sole power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
(iv) Shared power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See Exhibit A to the Schedule 13G filed by the Reporting Persons with the Securities and Exchange Commission on September 27, 2021.
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Madison Avenue International LP
Signature:
/s/ Eli Samaha
Name/Title:
Eli Samaha, as Manager of Madison Avenue GP, LLC, its General Partner
Date:
11/16/2026
Madison Avenue Partners, LP
Signature:
/s/ Eli Samaha
Name/Title:
Eli Samaha, as Managing Member of EMAI Management, LLC, its General Partner